Trial Profile
Evaluation of alternative oseltamivir (Tamiflu) dosing strategies for use during influenza prophylaxis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary) ; Probenecid
- Indications Influenza virus infections
- Focus Pharmacokinetics; Therapeutic Use
- 10 Sep 2009 Actual end date (Apr 2007) added as reported by ClinicalTrials.gov.
- 21 Sep 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 Apr 2007 Status changed from recruiting to in progress.